Form 4 for ENLT Enlight Renewable Energy Ltd.
Accepted 2026-05-14 07:28:15 ET · period of report 2026-05-12 · accession 0001178913-26-002663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-14 07:28 | 2026-05-12+ | ENLT | Haimovitz Lisa | VP, GC | M - OptEx | $19.87 | +7,703 | 15.7K | +96% | +$153.1K |
| DM | 2026-05-14 07:28 | 2026-05-12+ | ENLT | Haimovitz Lisa | VP, GC | F - Tax | $93.43 | -3,200 | 13.6K | -19% | -$299.0K |
| DM | 2026-05-14 07:28 | 2026-05-12+ | ENLT | Haimovitz Lisa | VP, GC | S - Sale+OE | $92.83 | -4,503 | 13.0K | -26% | -$418.0K |
| DM | 2026-05-14 07:28 | 2026-05-12+ | ENLT | Haimovitz Lisa | VP, GC | M - OptEx | $0.00 | -7,703 | 66.3K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-12 | M | A | 5,000 | $19.87 | 18,026 | D | — | — | (F1) Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F2) Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 2 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-12 | F | D | 1,117 | $92.67 | 16,909 | D | — | — | (F3) These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price. (F4) Represents a transaction price of NIS 269.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction. (F2) Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 3 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-12 | S | D | 3,883 | $92.67 | 13,026 | D | — | — | (F4) Represents a transaction price of NIS 269.57, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction. (F2) Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 4 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-13 | M | A | 2,703 | $19.87 | 15,729 | D | — | — | (F1) Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F2) Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 5 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-13 | F | D | 2,083 | $93.84 | 13,646 | D | — | — | (F3) These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price. (F5) Represents a transaction price of NIS 272.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction. (F2) Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 6 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-13 | S | D | 620 | $93.84 | 13,026 | D | — | — | (F5) Represents a transaction price of NIS 272.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction. (F2) Includes 6,513 restricted share units granted on April 21, 2024, with 3,256 vesting on April 24, 2027 and 3,257 vesting on April 24, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 7 | Derivative | Stock Options (right to buy) | 2026-05-12 | M | D | 5,000 | $0.00 | 69,043 | D | $19.87 · — to 2028-09-30 | 5,000 Ordinary shares, NIS 0.1 par value per share | (F1) Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F6) Stock options were granted on April 24, 2023, with 46,543 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027. (F6) Stock options were granted on April 24, 2023, with 46,543 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027. |
| 8 | Derivative | Stock Options (right to buy) | 2026-05-13 | M | D | 2,703 | $0.00 | 66,340 | D | $19.87 · — to 2028-09-30 | 2,703 Ordinary shares, NIS 0.1 par value per share | (F1) Represents an exercise price of NIS 61.52, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F7) Stock options were granted on April 24, 2023, with 43,840 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027. (F7) Stock options were granted on April 24, 2023, with 43,840 having vested on April 24, 2026 and 22,500 vesting on April 24, 2027. |